Daniella M Schwartz

Daniella M Schwartz

UNVERIFIED PROFILE

Are you Daniella M Schwartz?   Register this Author

Register author
Daniella M Schwartz

Daniella M Schwartz

Publications by authors named "Daniella M Schwartz"

Are you Daniella M Schwartz?   Register this Author

19Publications

489Reads

7Profile Views

Ca Influx Channel Inhibitor SARAF Protects Mice From Acute Pancreatitis.

Gastroenterology 2019 Sep 4. Epub 2019 Sep 4.

Epithelial Signaling and Transport Section, National Institute of Dental and Craniofacial Research, NIH, Bethesda MD, 20892. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2019.08.042DOI Listing
September 2019

STIM1 holds a STING in its (N-terminal) tail.

Cell Calcium 2019 Jun 7;80:192-193. Epub 2019 Mar 7.

Genetics and Pathogenesis of Allergy Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ceca.2019.03.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686850PMC
June 2019

Oncogenes calling on a lysosomal Ca channel.

EMBO Rep 2019 Apr 15;20(4). Epub 2019 Mar 15.

Epithelial Signaling and Transport Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.15252/embr.201947953DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446195PMC
April 2019

Janus kinases to jakinibs: from basic insights to clinical practice.

Rheumatology (Oxford) 2019 Feb;58(Supplement_1):i4-i16

Molecular Immunology and Inflammation Branch, National Institute of Arthritis, and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/key432DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657570PMC
February 2019

Brief Report: Drugs Implicated in Systemic Autoimmunity Modulate Neutrophil Extracellular Trap Formation.

Arthritis Rheumatol 2018 03 23;70(3):468-474. Epub 2018 Jan 23.

National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/art.40372
Publisher Site
http://dx.doi.org/10.1002/art.40372DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826843PMC
March 2018

JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.

Nat Rev Drug Discov 2017 Dec 6;16(12):843-862. Epub 2017 Nov 6.

Molecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrd.2017.201DOI Listing
December 2017

Erratum to: JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects.

Drugs 2017 07;77(11):1261

Molecular Immunology and Inflammation Branch, National Institute of Arthritis Musculoskeletal and Skin diseases, National Institutes of Health, Bethesda, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s40265-017-0772-7
Publisher Site
http://dx.doi.org/10.1007/s40265-017-0772-7DOI Listing
July 2017

Erratum to: JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects.

Drugs 2017 05;77(8):939

Molecular Immunology and Inflammation Branch, National Institute of Arthritis Musculoskeletal and Skin diseases, National Institutes of Health, Bethesda, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40265-017-0736-yDOI Listing
May 2017

JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects.

Drugs 2017 04;77(5):521-546

Molecular Immunology and Inflammation Branch, National Institute of Arthritis Musculoskeletal and Skin diseases, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40265-017-0701-9DOI Listing
April 2017

Decernotinib: A Next-Generation Jakinib.

Arthritis Rheumatol 2016 Jan;68(1):31-4

National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.39463DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026186PMC
January 2016

Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases.

Nat Rev Rheumatol 2016 Jan 3;12(1):25-36. Epub 2015 Dec 3.

Molecular Immunology &Inflammation Branch, and Translational Immunology Section, National Institute of Arthritis &Musculoskeletal and Skin Diseases, NIH, Building 10, 9000 Rockville Pike, Bethesda, Maryland 20892-1616, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrrheum.2015.167DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688091PMC
January 2016

The JAK-STAT pathway: impact on human disease and therapeutic intervention.

Annu Rev Med 2015 ;66:311-28

Molecular Immunology and Inflammation Branch, National Institute of Arthritis, Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland 20892; email:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1146/annurev-med-051113-024537DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634336PMC
September 2015

Palmoplantar pustules and osteoarticular pain in a 42-year-old woman.

J Am Acad Dermatol 2015 Mar 12;72(3):550-3. Epub 2014 Aug 12.

Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2014.07.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326625PMC
March 2015

CDK inhibitors upregulate BH3-only proteins to sensitize human myeloma cells to BH3 mimetic therapies.

Cancer Res 2012 Aug 12;72(16):4225-37. Epub 2012 Jun 12.

Division of Hematology/Oncology, Department of Medicine, Virginia Commonwealth University and the Massey Cancer Center, Institute of Molecular Medicine, Richmond, Virginia 23298, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-12-1118DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3421040PMC
August 2012